Transgender people would be covered under a new rule barring sex discrimination in federally funded health programs.» Read More
Halting tobacco sales at all of its drugstores caused people to buy 1% fewer packs of cigarettes in 13 states, USAT reports.
Tobacco firms are getting the equivalent of a tax break after the end of a federal assessment, USA Today reports.
Single people with incomes above $85,000 and married couples with more than $170,000 will pay more for Medicare Part B and Part D coverage.
Valeant buys AstraZeneca psoriasis drug after Amgen backs out.
The fund sold all its Mylan shares after it emerged that one of its products is in stock at a U.S. prison where death sentences are carried out.
Large insurers raised prices at a higher rate than smaller ones, and provider-owned plans tended to be more expensive, two studies found.
One in 3 insured consumers has had an unexpected medical bill in recent years, according to Consumer Reports. Here's how to prevent it.
Amgen has won federal approval for the second medicine in a new class of pricey biotech drugs that reduce artery-clogging cholesterol.
Katrina enabled Ochsner Baptist to hit the "reset button," said Ochsner Health System CEO Warner Thomas.
The Ice Bucket Challenge is back, even if it's not nearly as big as last year.
A new survey from CareerCast.com finds that 6 of the 10 top-paying jobs are in health care-related fields.
CVS customers in six states will get access to telehealth services starting in the fourth quarter.
With 11 reported cases and three recent deaths linked to plague, the CDC is warning doctors not to rule it out, NBC reports.
The healthcare secular theme isn't new, but is still very much in force.
The 40 percent tax on high-cost health plans is expected to hit 26 percent of employers in 2018
A female libido drug Addyi has been approval. Does that mean feminine versions of those classic Viagra ads? Probably not. Here's why.
Lower-income Obamacare customers can get help with out-of-pocket health expenses, but many people don't select eligible health plans
There are a number of diet and lifestyle choices that accompany Alzheimer's risk, according to a new study.
Swiss drugmaker Novartis said on Friday it had agreed to buy all remaining rights to Ofatumumab from Britain's GlaxoSmithKline.
Valeant is buying the company that just won approval to sell "female Viagra."
Get the best of CNBC in your inbox